相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular therapy in head and neck oncology
Jacques Bernier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTIN (TM); AZD2171) enhances radiation response and causes substantial physiological changes in lung tumour xenografts
K. J. Williams et al.
BRITISH JOURNAL OF RADIOLOGY (2008)
Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity
Toshirnitsu Tanaka et al.
CLINICAL CANCER RESEARCH (2008)
SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation
Kyle C. Cuneo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
New molecularly targeted therapies for lung cancer
Sophie Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma
Sophie de Boueard et al.
NEURO-ONCOLOGY (2007)
Radiation-induced cell signaling: inside-out and outside-in
Kristoffer Valerie et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248
Olga Potapova et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Sunitinib malate for the treatment of solid tumours: a review of current clinical data
Robert J. Motzer et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
External beam radiotherapy as curative treatment of prostate cancer
TM Pisansky
MAYO CLINIC PROCEEDINGS (2005)
Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition
D Zips et al.
CANCER RESEARCH (2005)
Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice
D Zips et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: Schedule-dependent enhancement of antitumor activity
KJ Williams et al.
CLINICAL CANCER RESEARCH (2004)